rss
Thorax 53:1030-1034 doi:10.1136/thx.53.12.1030
  • Original article

Increase in exhaled nitric oxide levels in patients with difficult asthma and correlation with symptoms and disease severity despite treatment with oral and inhaled corticosteroids

Table 1

Characteristics of patients with difficult asthma

No. 26
Sex (F/M) 19/7
Mean (SD) age (range) 38.8 (15.0) years (15–71)
 Women 37.9 (15.6)
 Men 41.0 (12.4)
Years symptomatic 19.2 (15.1)
Atopic status Atopic/non-atopic 20/6
No. of smokers 5
Treatment:
 Prednisolone n = 17 (12F/5M)
 ICS Fluticasone (n = 20) 2025 (1197) μg/day
 ICS Budesonide (n = 6) 3967 (2271) μg/day
Rescue β agonist MDI 8.1 (9.9) puffs/day
Lung function:
 PEF (% predicted) 64.2 (20.5)
 FEV1 (% predicted) 66.2 (21.6)
 FEV1/FVC 63.0 (16.4)
 PEFV (% mean) 67.1 (29.5)
 β agonist response 19.7 (median), 0–36 (range)
  • ICS = inhaled corticosteroid; MDI = multidose inhaler; PEF = peak expiratory flow; FEV1 = forced expiratory volume in one second; FVC = forced vital capacity; PEFV = diary card peak expiratory flow variability values are mean (SD) or median (range) where indicated.

This Article


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of Thorax.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.